73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo
CAR-T cell researchers optimistic about future of treating blood cancers

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl
Trends and hotspots in lung cancer surgery research reviewed over the last decade

Trends and hotspots in lung cancer surgery research reviewed over the last decade

by Health Data ScienceTrends of (a) annual scholarly outputs and (b) average field citation ratios in the world and top five countries in the field of lung cancer surgery, 2012-2021, and association b

Trends and hotspots in lung cancer surgery research reviewed over the last decade

by Health Data ScienceTrends of (a) annual scholarly outputs and (b) average field citation ratios in the world and top five countries in the field of lung cancer surgery, 2012-2021, and association b
Danish study finds drug reduces 'forever chemicals' in blood

Danish study finds drug reduces 'forever chemicals' in blood

FEBRUARY 29, 2024Credit: Pixabay/CC0 Public DomainA medication for high cholesterol can drastically cut "forever chemicals" (PFAS)—associated with an increased risk of cancer and banned in E

Danish study finds drug reduces 'forever chemicals' in blood

FEBRUARY 29, 2024Credit: Pixabay/CC0 Public DomainA medication for high cholesterol can drastically cut "forever chemicals" (PFAS)—associated with an increased risk of cancer and banned in E
Researchers target mutation that leads to pancreatic cancer

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le

Researchers target mutation that leads to pancreatic cancer

by Leslie Cantu,Medical University of South CarolinaCrystal structures of 12D5(K63S) in complex with KRAS(G12D)•GTPγS and with KRAS(G12D)•GDP. (A) A comparison of 12D5(K63S)–KRAS(G12D)•GTPγS (Le
New bone cancer drug improves survival rates by 50% in preclinical trials

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer
Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi
Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in
Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent
Therapeutic viruses help turbocharge the immune system against cancer

Therapeutic viruses help turbocharge the immune system against cancer

by Richard Harth,Arizona State UniversityThe illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus. A new study describes how

Therapeutic viruses help turbocharge the immune system against cancer

by Richard Harth,Arizona State UniversityThe illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus. A new study describes how